Skip to main content

For questions about financial assistance, call 1-844-DUPIXENT, option 1 or
click to learn more  

Results with
dupixent

Patient portrayal

A difference You CAN SEE AND FEEL

DUPIXENT was studied in two 24-week clinical trials in 284 patients ages 12 years and older with chronic
spontaneous urticaria (CSU) who continued to have hives despite taking H1 antihistamines. All patients
remained on antihistamines during the trials.

At 24 weeks, patients HAD:

Less itch*
  • Trial 1: 64% less itch on DUPIXENT vs 35% on
    placebo
  • Trial 2: 48% less itch on DUPIXENT vs 33% on
    placebo
Both itch and hives reduction†
  • Trial 1: 66% reduction on DUPIXENT vs 36% on
    placebo
  • Trial 2: 48% reduction on DUPIXENT vs 32% on
    placebo
RELIEF MAY BE POSSIBLE: ~2x AS MANY PATIENTS
HAD NO ITCH AND NO HIVES AT 24 WEEKS
  • Trial 1: 32% on DUPIXENT vs 13% on placebo
  • Trial 2: 30% on DUPIXENT vs 17% on placebo

*Patients rated their itch daily (on a scale from 0 to 3) for 7 days (maximum score of 21), and this number
was compared to their baseline score.

†Patients rated their hives daily (on a scale from 0 to 3) for 7 days (maximum score of 21). This score was added
to their itch severity score and compared to the baseline score.

THE MOST COMMON SIDE
EFFECTS IN CSU WERE:

  • injection site reactions

View the possible side effects of DUPIXENT.

TAKE YOUR NEXT STEP
TOWARD A DIFFERENT
TREATMENT FOR YOUR CSU

ASK YOUR DOCTOR ABOUT
DUPIXENT

Download the doctor discussion guide to ask
the right questions and get the most out of
your
appointment.

Download the
discussion guide

TALK TO A SPECIALIST WHO
CAN HELP

Your chronic hives may not be due to an allergy
—find a nearby specialist to explore a different
treatment option like DUPIXENT.

Find a specialist
near you